![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:F2RL1-CYSTM1 (FusionGDB2 ID:HG2150TG84418) |
Fusion Gene Summary for F2RL1-CYSTM1 |
![]() |
Fusion gene information | Fusion gene name: F2RL1-CYSTM1 | Fusion gene ID: hg2150tg84418 | Hgene | Tgene | Gene symbol | F2RL1 | CYSTM1 | Gene ID | 2150 | 84418 |
Gene name | F2R like trypsin receptor 1 | cysteine rich transmembrane module containing 1 | |
Synonyms | GPR11|PAR2 | C5orf32|ORF1-FL49 | |
Cytomap | ('F2RL1')('CYSTM1') 5q13.3 | 5q31.3 | |
Type of gene | protein-coding | protein-coding | |
Description | proteinase-activated receptor 2G-protein coupled receptor 11coagulation factor II (thrombin) receptor-like 1protease-activated receptor 2thrombin receptor-like 1 | cysteine-rich and transmembrane domain-containing protein 1UPF0467 protein C5orf32putative nuclear protein ORF1-FL49 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000296677, | ||
Fusion gene scores | * DoF score | 2 X 2 X 2=8 | 26 X 7 X 13=2366 |
# samples | 2 | 34 | |
** MAII score | log2(2/8*10)=1.32192809488736 | log2(34/2366*10)=-2.79884342220209 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: F2RL1 [Title/Abstract] AND CYSTM1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | F2RL1(76115089)-CYSTM1(139622890), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | F2RL1-CYSTM1 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. F2RL1-CYSTM1 seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | F2RL1 | GO:0002690 | positive regulation of leukocyte chemotaxis | 17991872 |
Hgene | F2RL1 | GO:0002741 | positive regulation of cytokine secretion involved in immune response | 11441110 |
Hgene | F2RL1 | GO:0007204 | positive regulation of cytosolic calcium ion concentration | 10725339 |
Hgene | F2RL1 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway | 19781631 |
Hgene | F2RL1 | GO:0030193 | regulation of blood coagulation | 17848177 |
Hgene | F2RL1 | GO:0030836 | positive regulation of actin filament depolymerization | 17500066 |
Hgene | F2RL1 | GO:0032930 | positive regulation of superoxide anion generation | 11714832 |
Hgene | F2RL1 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway | 18622013 |
Hgene | F2RL1 | GO:0035926 | chemokine (C-C motif) ligand 2 secretion | 21501162 |
Hgene | F2RL1 | GO:0042119 | neutrophil activation | 15155775 |
Hgene | F2RL1 | GO:0043122 | regulation of I-kappaB kinase/NF-kappaB signaling | 18453611 |
Hgene | F2RL1 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 11413129 |
Hgene | F2RL1 | GO:0043311 | positive regulation of eosinophil degranulation | 11714832 |
Hgene | F2RL1 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 16410250 |
Hgene | F2RL1 | GO:0046328 | regulation of JNK cascade | 16410250 |
Hgene | F2RL1 | GO:0046329 | negative regulation of JNK cascade | 19781631 |
Hgene | F2RL1 | GO:0046330 | positive regulation of JNK cascade | 11413129 |
Hgene | F2RL1 | GO:0050702 | interleukin-1 beta secretion | 15155775 |
Hgene | F2RL1 | GO:0050900 | leukocyte migration | 15155775 |
Hgene | F2RL1 | GO:0050927 | positive regulation of positive chemotaxis | 17991872 |
Hgene | F2RL1 | GO:0051607 | defense response to virus | 18453611|19494303 |
Hgene | F2RL1 | GO:0060100 | positive regulation of phagocytosis, engulfment | 21501162 |
Hgene | F2RL1 | GO:0061028 | establishment of endothelial barrier | 20826780 |
Hgene | F2RL1 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 10725339 |
Hgene | F2RL1 | GO:0070963 | positive regulation of neutrophil mediated killing of gram-negative bacterium | 21501162 |
Hgene | F2RL1 | GO:0072608 | interleukin-10 secretion | 18453611 |
Hgene | F2RL1 | GO:0090195 | chemokine secretion | 19494303|21501162 |
Hgene | F2RL1 | GO:0090198 | negative regulation of chemokine secretion | 19865078 |
Hgene | F2RL1 | GO:0097029 | mature conventional dendritic cell differentiation | 16478888 |
Hgene | F2RL1 | GO:2000484 | positive regulation of interleukin-8 secretion | 15155775|17404307|18622013|19865078 |
Hgene | F2RL1 | GO:2000778 | positive regulation of interleukin-6 secretion | 11447194|15155775 |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | STAD | TCGA-D7-A4Z0-01A | F2RL1 | chr5 | 76115089 | + | CYSTM1 | chr5 | 139622890 | + |
Top |
Fusion Gene ORF analysis for F2RL1-CYSTM1 |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-3UTR | ENST00000296677 | ENST00000509789 | F2RL1 | chr5 | 76115089 | + | CYSTM1 | chr5 | 139622890 | + |
Frame-shift | ENST00000296677 | ENST00000261811 | F2RL1 | chr5 | 76115089 | + | CYSTM1 | chr5 | 139622890 | + |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for F2RL1-CYSTM1 |
![]() |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
F2RL1 | chr5 | 76115089 | + | CYSTM1 | chr5 | 139622889 | + | 0.001069298 | 0.99893063 |
F2RL1 | chr5 | 76115089 | + | CYSTM1 | chr5 | 139622889 | + | 0.001069298 | 0.99893063 |
![]() |
![]() |
Top |
Fusion Protein Features for F2RL1-CYSTM1 |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:76115089/:139622890) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for F2RL1-CYSTM1 |
![]() |
Top |
Fusion Gene PPI Analysis for F2RL1-CYSTM1 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for F2RL1-CYSTM1 |
![]() (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for F2RL1-CYSTM1 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | F2RL1 | C0021368 | Inflammation | 2 | CTD_human |
Hgene | F2RL1 | C0017160 | Gastroenteritis | 1 | CTD_human |
Hgene | F2RL1 | C0025202 | melanoma | 1 | CTD_human |
Hgene | F2RL1 | C0033774 | Pruritus | 1 | CTD_human |
Hgene | F2RL1 | C0151744 | Myocardial Ischemia | 1 | CTD_human |
Tgene | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |